Ovarian carcinoma and digital ischaemia

Clinical and Experimental Dermatology

Volumn 21, Issue 5, 1996, Pages 381-382

  Maurice, P D L ^a  

^a St Albans City Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; PROSTACYCLIN;

ADULT; ARTICLE; CASE REPORT; CYANOSIS; FEMALE; GANGRENE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; OVARY CARCINOMA; PRIORITY JOURNAL;

CARCINOMA, ENDOMETRIOID; FEMALE; FINGERS; GANGRENE; HUMANS; ISCHEMIA; MIDDLE AGED; OVARIAN NEOPLASMS;

EID: 0030478804     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2230.1996.tb00130.x     Document Type: Article

References (6)

1. Palmer HM. Digital vascular disease and malignant disease. Br J Dermatol 1974; 91: 476-7.
2. Tolosa-Vilella C, Ordi-Ros J, Vilardell-Tarres M et al. Raynaud's phenomenon and positive antinuclear antibodies in a malignancy. Ann Rheum Dis 1990; 49: 935-6.
3. Smith RA, Propper DJ, Harvey AR. Ovarian carcinoma and Raynaud's phenomenon. Br J Dermatol 1995; 132: 152-3.
4. Hawley PR, Johnston AW, Rankin JT. Association between digital ischaemia and malignant disease. Br Med J 1967; 3: 208-12.
5. Friedman SA, Bienenstock H, Richter IH. Malignancy and arteriopathy: a report of two cases. Angiology 1969; 20: 136-43.
6. Freundlich B, Makover D, Maul GG. A novel antinuclear antibody associated with a lupus-like paraneoplastic syndrome. Ann Intern Med 1988; 109: 295-7.